Literature DB >> 16860157

Pathology of bronchopulmonary dysplasia.

Jacqueline J Coalson1.   

Abstract

Over the past three decades, advances in prenatal and neonatal intensive care have contributed to marked improvements in survival rates for extremely immature infants born during the canalicular phase of lung development at 24 to 26 weeks, a time when alveolar and distal vascular development is rapidly occurring. The histopathological lesions of severe airway injury and alternating sites of overinflation and fibrosis in "old" BPD have been replaced in "new" BPD with the pathologic changes of large, simplified alveolar structures, a dysmorphic capillary configuration, and variable interstitial cellularity and/or fibroproliferation. Airway and vascular lesions, when present, tend to be present in infants, who over time develop more severe disease. The concept that "new" BPD results in an arrest in alveolization should be modified to that of an impairment in alveolization as evidence shows that short ventilatory times and/or the use of nCPAP allow continued alveolar formation.

Entities:  

Mesh:

Year:  2006        PMID: 16860157     DOI: 10.1053/j.semperi.2006.05.004

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  110 in total

1.  Hyperoxia-induced changes in estradiol metabolism in postnatal airway smooth muscle.

Authors:  Yvette N Martin; Logan Manlove; Jie Dong; William A Carey; Michael A Thompson; Christina M Pabelick; Hitesh C Pandya; Richard J Martin; Dennis A Wigle; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

2.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.

Authors:  Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

Review 3.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

4.  Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Regulates LPS-Induced Inflammation and Alveolar Remodeling in the Developing Lung.

Authors:  Heather L Menden; Sheng Xia; Sherry M Mabry; Angels Navarro; Michael F Nyp; Venkatesh Sampath
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

5.  Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines.

Authors:  J Davin Miller; John T Benjamin; David R Kelly; David B Frank; Lawrence S Prince
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-19       Impact factor: 5.464

6.  Adverse early-life environment impairs postnatal lung development in mice.

Authors:  Pui Y Lai; Xigang Jing; Teresa Michalkiewicz; Brianna Entringer; Xingrao Ke; Amber Majnik; Alison J Kriegel; Pengyuan Liu; Robert H Lane; Girija G Konduri
Journal:  Physiol Genomics       Date:  2019-08-02       Impact factor: 3.107

7.  Neonatal hyperoxia increases sensitivity of adult mice to bleomycin-induced lung fibrosis.

Authors:  Min Yee; Bradley W Buczynski; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-20       Impact factor: 6.914

Review 8.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 9.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Exploiting cellular-developmental evolution as the scientific basis for preventive medicine.

Authors:  J S Torday; V K Rehan
Journal:  Med Hypotheses       Date:  2009-01-14       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.